海外の治験の状況「1」での検索結果
8489件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy
- Sarcoma, Soft Tissue;Soft Tissue Sarcoma
- United States
- 2014-11-20
Not recruiting
- Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment
- HER-2 Positive Gastric Cancer;Gastrooesophageal Cancer;Esophageal Cancer;HER-2 Positive Gastric Cancer;Gastrooesophageal Cancer;Esophageal Cancer;HER-2 Positive Gastric Cancer;Gastrooesophageal Cancer;Esophageal Cancer;HER-2 Positive Gastric Cancer;Gastrooesophageal Cancer;Esophageal Cancer
- United States
- 2014-10-15
Not Recruiting
- This study is designed to assess the efficacy and safety of filanesib + carfilzomib versus single-agent carfilzomib in patients with multiple myeloma who have received at least 2 prior lines of therapy.
- Multiple Myeloma MedDRA version: 17.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, Belgium, Canada, Czech Republic, France, Germany, Greece, Hungary, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom, United States
- 2014-09-05
Not recruiting
- Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment
- Infection, Human Immunodeficiency Virus
- Argentina, Brazil, Chile, China, Colombia, Kenya, Mexico, Peru, Romania, Russian Federation, South Africa, Thailand, Ukraine
- 2014-08-25
Not recruiting
- Enzalutamide & Dutasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.
- Prostate Cancer;Prostate Cancer
- United States
- 2014-08-07
Not recruiting
- A Pharmacokinetic Study to Assess the Influence of Simultaneous CYP3A4 and P-glycoprotein Inhibition on E7080 Pharmacokinetics Following Single Dose Oral Administration of 5 mg E7080 to Healthy Volunteers
- Healthy Volunteers
- United States
- 2014-07-21
Not recruiting
- Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery
- Metastatic Melanoma;Mucosal Melanoma;Stage IV Cutaneous Melanoma AJCC v6 and v7;Stage IV Uveal Melanoma AJCC v7;Unresectable Melanoma
- United States
- 2014-06-05
Not recruiting
- A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy
- Small Cell Lung Cancer;Platinum-sensitive;Small Cell Lung Cancer;Platinum-sensitive
- Canada
- 2014-05-29
Not recruiting
- A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects
- Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus
- Canada, France, Germany, Spain, United States
- 2014-04-17
Not recruiting
- Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
- Ventricular Tachycardia;Ventricular Arrhythmia
- Canada
- 2014-04-04
Not recruiting
- Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma
- Stage III or IV Melanoma;Stage III or IV Melanoma;Stage III or IV Melanoma;Stage III or IV Melanoma
- United States
- 2014-03-27
Not recruiting
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
- Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2014-01-19
Not recruiting
- A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
- Differentiated Thyroid Cancer (DTC);Poorly Differentiated Thyroid Cancer
- United States
- 2014-01-17
Not Recruiting
- Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer MedDRA version: 20.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, Czech Republic, European Union, Germany, Greece, Netherlands, United Kingdom, United States
- 2013-09-02
Not recruiting
- Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
- Endometrial Cancer;Endometrial Cancer;Endometrial Cancer;Endometrial Cancer
- Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Czech Republic, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom, United States
- 2013-01-09
Not recruiting
- Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
- Colorectal Cancer Metastatic
- Austria, Belgium, Canada, China, Czech Republic, Czechia, France, Germany, Italy, Korea, Republic of, Poland, Singapore, Spain, United Kingdom, United States
- 2011-11-24
Not recruiting
- Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
- Colorectal Cancer Metastatic
- Ireland, United States
- 2011-02-16
Not Recruiting
- A 28-week trial to determine treatment optimization with once-daily TOUJEO in combination with prandial rapid-acting insulin analogue in patients with type 1 diabetes previously uncontrolled on twice daily basal insulin as part of basal-bolus therapy
- Type 1 diabetes mellitus br>MedDRA version: 20.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Belgium, Canada
- 2015-07-31
Not recruiting
- Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
- Breast Cancer;Breast Cancer;Breast Cancer;Breast Cancer
- United States
- 2015-06-25
Not recruiting
- Phase II Trial of HM61713 for the Treatment of =2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
- Non Small Cell Lung Cancer;Non Small Cell Lung Cancer;Non Small Cell Lung Cancer
- Australia, Canada, Germany, Italy, Korea, Republic of, Malaysia, Philippines, Spain, Taiwan, United States
- 2015-06-22